Funding
← Back to your selection

Qiming Venture Partners

Activity from announced rounds

Activity in this selectionChina
Rounds participated in
7
Confirmed lead rounds
—
7 roles undisclosed
New companies
6
First participation on record · 1 follow-on
Funding in participating rounds
$606.5M
7 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series A2
Series B1
Series C+1

By primary sector

Biotech5
Healthtech2

By country

China7

Rounds

7 in this selection
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+
Role not disclosed
Pulnovo Medical

Develops interventional therapies for pulmonary hypertension and heart failure

$100MStrategic
Role not disclosed
Syneron Bio

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries B
Role not disclosed
StairMed

Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases

CN¥500MStrategic
Role not disclosed
Oricell Therapeutics

Develops next-generation cell therapies for oncology and immunology

$70MSeries C1
Role not disclosed